1. Impact of Increased Heart Rate on Clinical Outcomes in Hypertension

   • Paolo Palatini
   • Athanase Benetos
   • Stevo Julius

   Current Opinion 17 September 2012 Pages: 133 - 144

   

2. HMG-CoA Reductase Inhibitors in Chronic Heart Failure

   • Ulrich Laufs
   • Florian Custodis
   • Michael Böhm

   Leading Article 17 September 2012 Pages: 145 - 154

   

3. Psychiatric and Substance Use Disorders in Individuals with Hepatitis C

   • Jennifer M. Loftis
   • Annette M. Matthews
   • Peter Hauser

   Therapy in Practice 17 September 2012 Pages: 155 - 174

   

4. Solifenacin in Overactive Bladder Syndrome

   • Christopher K. Payne

   Review Article 17 September 2012 Pages: 175 - 190

   

5. Emerging Selective Estrogen Receptor Modulators

   • Tatjana Elène Vogelvang
   • Marius Jan van der Mooren
   • Peter Kenemans

   Review Article 17 September 2012 Pages: 191 - 221

   

6. Tramadol Sustained-Release Capsules

   • Gillian M. Keating

   Adis Drug Profile 17 September 2012 Pages: 223 - 230

   

7. Tramadol Sustained-Release Capsules

   • Miquel Casals

   Adis Drug Profile 17 September 2012 Pages: 231 - 231

8. Tramadol Sustained-Release Capsules

   • Maurizio Evangelista

   Adis Drug Profile 17 September 2012 Pages: 231 - 232

9. Tramadol Sustained-Release Capsules

   • Sergio Canavero
   • Vincenzo Bonicalzi

   Adis Drug Profile 17 September 2012 Pages: 232 - 232

10. Perindopril

    • Monique P. Curran
    • Paul L. McCormack
    • Dene Simpson

    Adis Drug Evaluation 17 September 2012 Pages: 235 - 255

    

11. Indapamide Sustained Release

    • Dean M. Robinson
    • Keri Wellington

    Adis Drug Evaluation 17 September 2012 Pages: 257 - 271